From the trastuzumab era to new target therapies: beyond revolution

Ann Oncol. 2007 Jun:18 Suppl 6:vi1-4. doi: 10.1093/annonc/mdm214.
No abstract available

Publication types

  • Meta-Analysis
  • Review

MeSH terms

  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Clinical Trials, Phase III as Topic / methods
  • Clinical Trials, Phase III as Topic / trends*
  • Drug Delivery Systems / methods
  • Drug Delivery Systems / trends*
  • Female
  • Humans
  • Neoplasms / blood supply
  • Neoplasms / drug therapy*
  • Neoplasms / metabolism
  • Randomized Controlled Trials as Topic / methods
  • Randomized Controlled Trials as Topic / trends*
  • Trastuzumab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Trastuzumab